Stocks to buy

Penny stocks were the talk of the town back in 2021, especially those in the technology and biotech sectors. However, so far in 2023, most penny stocks have remained dormant with barely any price action to the upside. That mostly has to do with rate hikes and funding issues. Investors are rightfully uncomfortable with unprofitable
0 Comments
I used Bard AI to help recommend blue-chip stocks for July. Right off the bat, it’s clear that Bard isn’t considering recent events in recommending the shares it has. Most of the rationale it offers in picking the shares centers on long-term factors. That’s fine, given that long-term investing produces better average returns. But it also suggests
0 Comments
Some stocks have skyrocketed year to date. Indeed, shares of some technology companies more than doubled over the last six months. This rally has been fueled by improving investor sentiment and excitement about artificial intelligence. These hypergrowth stocks appear to be carrying their momentum into the year’s second half, continuing to rally to new heights.
0 Comments
As we brace for a potential recession looming on the horizon, many investors are recalibrating their portfolios in search of low-risk stocks. If you’re in sweats thinking about financial risk, and your concern rests with capital preservation, you might want to avoid high-flying growth stocks. To be fair, growth stocks should hold a pivotal spot
0 Comments
Meta Platforms (NASDAQ:META) stock differentiates itself in the U.S. market with its emphasis on artificial intelligence and the metaverse. Its involvement in machine learning technology and generative AI sets it apart for future innovations. Investors appreciate the company’s current valuation and recognize its successful strategies of reinvesting in platforms like Instagram and implementing cost-cutting measures.
0 Comments
In the grand theater of the stock market, bargain stocks have often played a leading role in captivating discerning investors. Those who understand the essence of buying robust businesses at bargain prices can attest to this strategy’s exponential wealth creation opportunity. The best companies may take a hit during recessions, yet investors with an eye
0 Comments
Rivian Automotive (NASDAQ:RIVN) stock surges as strong deliveries fuel investor optimism. The company exceeded analysts’ delivery expectations for the quarter, showcasing continued growth in the electric vehicle market. RIVN stock has experienced a significant surge driven by retail investors, with a 54% increase over the past five sessions and an 81% gain for the month.
0 Comments
Artificial Intelligence (AI) has received incredible attention this year due to the release of OpenAI’s advanced chatbot, ChatGPT.  But ChatGPT is fortunately not the only chatbot to be released. Many developers have released their own version of the AI including Bing ChatGPT, Jasper, Perplexity AI and You Chat. For this article, I decided to ask Bing ChatGPT
0 Comments
Penny stocks have always interested many investors. Indeed, this interest comes from many places. Some investors like the volatility of these stocks, and the ability to buy a large amount of shares at one time. Others focus on the immense upside potential most penny stocks provide. Of course, this extremely high upside also means these
0 Comments
Looking for investment opportunities in dividend stocks? Look no further! Discover the potential of cheap dividend stocks, undervalued dividend stocks, and high-yield cheap stocks that are worth considering. These stocks offer the enticing prospect of regular quarterly dividend payments. Such payments can be a reliable source of income for investors, even during market downturns. While
0 Comments
Momentum stocks offer investors the opportunity to capitalize on strong and continued upward price changes. At the same time, it is an inherently and undeniably risky trading method. Investing in momentum stocks can sometimes counter the notion that time in the market yields better results on average than timing the market.  But for those who
0 Comments